Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: An unexplored triangle

American Journal of Gastroenterology

Volumn 93, Issue 3, 1998, Pages 394-400

  Xia, Harry Hua Xiang ^a   Talley, Nicholas J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATROPHIC GASTRITIS; DATA ANALYSIS; DATA BASE; DISEASE ASSOCIATION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MEDICAL RECORD; PRIORITY JOURNAL; REFLUX ESOPHAGITIS;

ESOPHAGITIS, PEPTIC; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 0032033970     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00394.x     Document Type: Article

References (114)

1. 1. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans 1994;61:177-241.
2. 2. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
3. 3. Wotherspoon AC, Prtiz-Hidalgo C, Falzon MR, et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6.
4. 4. Stolte M. Helicobacter pylori gastritis and gastric MALT-lymphoma. Lancet 1992;339:745-6.
5. 5. El-Serag HB, Sonnenberg A. Opposing time trends of peptic and reflux disease. Gastroenterology 1997;112:A113.
6. 6. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988;41:184-97.
7. 7. Blaser MJ. Helicobacter pylori infection and adenocarcinoma of distal stomach. Eur J Gastroenterol Hepatol 1993;5(suppl 1):S99-102.
8. 8. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence if adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265: 1287-9.
9. 9. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104;510-3.
10. 10. Schütze K, Hentschel E, Dragosics B, et al. Helicobacter pylori reinfection with identical organisms: Transmission by the patients' spouses. Gut 1995;36:831-3.
11. 11. Labenz J, Tillenburg B, Peitz U, et al. Long-term consequences of Helicobacter pylori eradication: Clinical aspects. Scand J Gastroenterol 1996;31(suppl 215):111-5.
12. 12. Labenz J, Blum AL, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
13. 13. Sacca N, De Medici A, Rodino S, et al. Reflux esophagitis: A complication of Helicobacter pylori (HP) eradication therapy. Gut 1996;39(suppl 3):A35.
14. 14. Kuipers EJ, Klinkenberg-Knol EC, Havu N, et al. Helicobacter pylori and development of atrophic gastritis during acid suppressive therapy. Gastroenterology 1995;108:A137.
15. 15. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: Implications for long-term safety. Am J Gastroenterol 1995;90:1401-6.
16. 16. Lamberts R, Creutzfeldt W, Struber HG. et al. Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993;104:1356-70.
17. 17. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334: 1018-22.
18. 18. Heikkinen M, Pikkarainen P, Takala J, et al. Etiology of dyspepsia: Four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 1995;30:519-23
19. 19. Mansi C, Savarino V, Mela GS, et al. Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients. Am J Gastroenterol 1993;88:1011-5.
20. 20. Warndorff DK, Knottnerus JA, Huijnen LGL, et al. How well do general practitioners manage dyspepsia? J R Coll Gen Pract 1989; 39:499-502.
21. 21. Lance P, Gibson-Glubb S, Gazzard JA, et al. Chronic dyspepsia pain in general practice - its causes and diagnosis. Postgrad Med J 1985; 61:411-3.
22. 22. Kagevi I, Lofstedt S, Persson L-G. Endoscopic findings and diagnoses in unselected dyspeptic patients at primary health care center. Scand J Gastroenterol 1989;245:145-50.
23. 23. Loof L, Gotell P, Elfberg B. The incidence of reflux esophagitis. A study of endoscopy reports from a defined catchment area in Sweden. Scand J Gastroenterol 1993;28:113-8.
24. 24. Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982;307: 1547-52.
25. 25. Dent J, Holloway RH, Toouli J, et al. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux. Gut 1988;29:1020-8.
26. 26. Kahrilas PJ, Dodds WJ, Hogan WJ, et al. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 1986;91:897-904.
27. 27. Ahtaridis G, Snape WJ, Cohen S. Clinical and manometric findings in benign peptic strictures of the esophagus. Dig Dis Sci 1979;24: 858-61.
28. 28. Hunt RH. The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1995;9(suppl 1):3-7.
29. 29. Boyd EJS. The prevalence of esophagitis in patients with duodenal ulcer or ulcer-like dyspepsia. Am J Gastroenterol 1996;91:1539-43.
30. 30. Ohara S, Sekine H, Iijima K, et al. Gastric mucosal atrophy and prevalence of Helicobacter pylori in reflux esophagitis of the elderly. Jpn J Gastroenterol 1996;93:235-9.
31. 31. Sekiguchi T, Shirota T, Horikoshi T, et al. Helicobacter pylori infection and severity of reflux esophagitis. Gastroenterology 1996; 110:A755.
32. 32. Cargill G, Atlan P, Tudor D, et al. Association of Helicobacter pylori and reflux esophagitis in symptomatic children. Gastroenterology 1994;106:A59.
33. 33. Rosioru C, Glassman MS, Halata MS, et al. Esophagitis and Helicobacter pylori in children: Incidence and therapeutic implications. Am J Gastroenterol 1993;88:510-3.
34. 34. De Koster E, Ferhat M, Deprez C, et al. Helicobacter pylori, gastric histology and gastro-oesophageal reflux disease. Gut 1995;37(suppl 1):A36.
35. 35. Coelho LGV, Das SS, Payne A, et al. Campylobacter pylori in esophagus, antrum and duodenum. A histological and microbiological study. Dig Dis Sci 1989;34:445-8.
36. 36. Fallingborg J, Agnholt J, Moller-Peterson J, et al. Campylobacter pylori in esophagus. Dig Dis Sci 1989;34:18-23.
37. 37. Grebenev AL. Helicobacter pylori (HP) and reflux esophagitis. Am J Gastroenterol 1994;89:1372 (abstract).
38. 38. O'Connor HJ, Cunnane K. Helicobacter pylori and gastro-oesophageal reflux disease - A prospective study. Irish J Med Sci 1994;163: 369-73.
39. 39. Galimov O, Fyodorov S, Nurtdinov M, et al. Helicobacter pylori in esophageal reflux (ER). Gut 1996;39(suppl 3):A193.
40. 40. Hackelsberger A, Schultze V, Gunther T, et al. Relation between H. pylori-gastritis and GERD. Gut 1996;39(suppl 3):A63.
41. 41. Newton M, Bryan R, Burnhan WR, et al. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagitis. Gut 1997; 40:9-13.
42. 42. Werdmuller BFM, Loffeld RJLF. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci 1997; 42:103-5.
43. 43. Haruma K, Mihara M, Kawaguchi H, et al. Low prevalence of Helicobacter pylori infection in patients with reflux esophagitis. Gastroenterology 1996;110:A130.
44. 44. Befrits R, Granstrom M, Rylander M, et al. Helicobacter pylori in 205 consecutive endoscopy patients. Scand J Infect Dis 1993;25:185-91.
45. 45. Cheng EH, Bermanski P, Silversmith M. Prevalence of Campylobacter pylori in oesophagitis, gastritis, and duodenal disease. Arch Intern Med 1989;149:1373-5.
46. 46. Boixeda D, Gisbert JP, Canton R, et al. Is there any association between Helicobacter pylori infection and peptic esophagitis? Med Clin 1995;105:774-7.
47. 47. Liston R, Pitt MA, Banerjee AK. Reflux oesophagitis and Helicobacter pylori infection in elderly patients. Postgrad Med J 1996;72: 221-3.
48. 48. Karttunen T, Niemela S, Lehtola J. Helicobacter pylori in dyspeptic patients: Quantitative association with severity of gastritis, intragastric pH, and serum gastrin concentration. Scand J Gastroenterol 1991;26(suppl 186):124-34.
49. 49. Testoni PA, Colombo E, Cattani L, et al. Helicobacter pylori serology in chronic gastritis with antral atrophy and negative histology for Helicobacter-like organisms. J Clin Gastroenterol 1996;22:182-5.
50. 50. Karnes WE, Samloff IM, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-74.
51. 51. Rubin CE. Are there three types of Helicobacter pylori gastritis? Gastroenterology 1997;112:2108-10.
52. 52. Genta RM, Huberman RM, Graham DY. The gastric cardia in Helicobacter pylori infection. Hum Pathol 1994;25:915-9.
53. 53. Fink SM, Barwick KW, DeLuca V, et al. The association of histologic gastritis with gastroesophageal reflux and delayed gastric emptying. J Clin Gastroenterol 1984;6:301-9.
54. 54. McCallum RW, Berkowitz DM, Lerner E. Gastric emptying in patients with gastroesophageal reflux. Gastroenterology 1981;80:285-91.
55. 55. McCallum RW, Fink SM, Lerner E, et al. Effects of metoclorpramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. Gastroenterology 1983;84:1773-7.
56. 56. Behar J, Ramsey G. Gastric emptying and antral motility in reflux esophagitis. Gastroenterology 1978;74:253-6.
57. 57. Moore SC, Malagelada JR, Shorter RG, et al. Interrelationships among gastric mucosal morphology, secretion, and motility in peptic ulcer disease. Dig Dis Sci 1986;31:673-84.
58. 58. Testoni PA, Bagnolo F, Masci E, et al. Different interdigestive antroduodenal motility patterns in chronic antral gastritis with and without Helicobacter pylori infection. Dig Dis Sci 1993;38:2255-61.
59. 59. Murakami K, Fujioka T, Shiota K, et al. Influence of Helicobacter pylori infection and the effects of its eradication on gastric emptying in non-ulcerative dyspepsia. Eur J Gastroenterol Hepatol 1995; 7(suppl 1):S93-7.
60. 60. Barnett JL, Behler EM, Appelman HD, et al. Campylobacter pylori is not associated with gastroparesis. Dig Dis Sci 1989;34:1677-80.
61. 61. Tucci A, Corinaldesi R, Stanghellini V. Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology 1992;103:768-74.
62. 62. Wegener M, Borsch G, Schaffstein J, et al. Are dyspeptic symptoms in patients with Campylobacter pylori-associated type B gastritis linked to delayed emptying? Am J Gastroenterol 1988;83:737-40.
63. 63. Pieramico O, Ditschuneit H, Malfertheiner P. Gastrointestinal motility in patients with nonulcer dyspepsia: A role for Helicobacter pylori infection? Am J Gastroenterol 1993;88:364-8.
64. 64. Minocha A, Mokshagundam S, Gallo SH, et al. Alternation in upper gastrointestinal motility in Helicobacter pylori nonulcer dyspepsia. Am J Gastroenterol 1994;89:1797-800.
65. 65. Chang C-S, Chen G-H, Kao C-H, et al. The effect of Helicobacter pylori infection on gastric emptying of digestible and indigestible solids in patients with nonulcer dyspepsia. Am J Gastroenterol 1996; 91:474-9.
66. 66. Kuipers EJ, Uyterlande AM, Nelis GF, et al. Long-term sequelae of Helicobacter pylori-associated gastritis. Lancet 1995;345:1525-8.
67. 67. Asaka M, Kato M, Kudo M, et al. Atrophic changes of gastric mucosa are caused by Helicobacter pylori infection rather than aging: Studies in asymptomatic Japanese adults. Helicobacter 1996;1:52-6.
68. 68. Correa P, Haeszel W, Cuello C, et al. Gastric precancerous process in a high risk population: Cohort follow-up. Cancer Res 1990;50:4737-40.
69. 69. Ihamaki T, Saukkonen M, Siurala M. Long-term observation of subjects with normal mucosa and with superficial gastritis: Results of 23-27 years' follow-up examinations. Scand J Gastroenterol 1978; 13:771-5.
70. 70. Villako K, Kekki M, Maaroos HI, et al. Chronic gastritis: Progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol 1991;26(suppl 186):135-41.
71. 71. Kuipers EJ, van Uffelen CWJ, Pale G, et al. Helicobacter pylori and gastric mucosal atrophy. A serological long-term follow-up study. Am J Gastroenterol 1994;89:1307 (abstract)
72. 72. Sakaki N. Momma K, Egawa N, et al. The influence of Helicobacter pylori infection on the progression of gastric mucosal atrophy and occurrence of gastric cancer. Eur J Gastroenterol Hepatol 1995; 7(suppl 1):S59-62.
73. 73. Correa P. A human model of gastritis carcinogenesis. Cancer Res 1988;48:3554-60.
74. 74. Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am 1993;22:89-104.
75. 75. The ECP-EURONUT Intestinal Metaplasia Study Group. The prevalence of Helicobacter pylori infection in patients with intestinal metaplasia and in controls: A serological and histological study in four United Kingdom centres. Eur J Cancer Prevent 1994;3(suppl 2):69-73.
76. 76. Craanen ME, Dekker W, Blok P, et al. Intestinal metaplasia and Helicobacter pylori: An endoscopic bioptic study of the gastric antrum. Gut 1992;33:16-20.
77. 77. Sipponen P, Kimura K. Intestinal metaplasia, atrophic gastritis and stomach cancer: Trend over time. Eur J Gastroenterol Hepatol 1994; 6(suppl 1):S79-83.
78. 78. Hessey SJ, Spencer J, Wyatt JI, et al. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut 1990;31: 134-8.
79. 79. O'Rourke J, Lee A, Fox JG. An ultrastructural study of Helicobacter mustelae and evidence of a specific association with gastric mucosa. J Med Microbiol 1992;36:420-7.
80. 80. Kekki M, Sipponen P, Siurala M. Progression of antral and body gastritis in patients with active and healed duodenal ulcer and duodenitis. Scand J Gastroenterol 1984;19:382-8.
81. 81. Beales I, Crabtree JE, Covacci A, et al. Antibodies to CagA protein in patients with H. pylori infection and atrophic gastritis. Gut 1995; 37(suppl 1):A37 (abstract).
82. 82. Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognization of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991;338:332-5.
83. 83. Crabtree JE, Wyatt JI, Sobala GM, et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993;34:1339-43.
84. 84. Negrini R, Lisato L, Zanella I, et al. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 1991;101:437-45.
85. 85. Faller G, Steininger H, Eck M, et al. Antigastric autoantibodies in Helicobacter pylori gastritis: Prevalence, in situ binding sites and clues for clinical relevance. Virchows Archiv 1996;427:483-6.
86. 86. Uibo R, Vorobjova T, Metskula K, et al. Association of Helicobacter pylori and gastric autoimmunity: A population-based study. FEMS Immunol Med Microbiol 1995;11:65-8.
87. 87. Dixon MF. Histological responses to Helicobacter pylori infection: Gastritis, atrophy and preneoplasia. Bailliere's Clin Gastroenterol 1995;9:467-86.
88. 88. Sobala GM, O'Connor HJ, Dewar EP, et al. Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol 1993;46:235-40.
89. 89. Johnson D. Gastric ulcer: Classification, blood group characteristics and pathogenesis. Ann Surg 1968;162:996-1004.
90. 90. Ruiz B, Correa P, Torrado J, et al. Lowis antigens and the prevalence of Helicobacter pylori infection, peptic ulcer and gastric carcinoma. Am J Gastroenterol 1994;89:1331 (abstract).
91. 91. Boren T, Falk P, Roth KA, et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993;262:1892-5.
92. 92. Azuma T, Konish J, Tanaka Y, et al. Contribution of HLA-DQA gene to hosts response against H pylori. Lancet 1994;343:542-3.
93. 93. Beales ILP, Davey N, Scunes D, et al. HLA Class II type and H. pylori-induced gastric atrophy. Gut 1994;35(suppl 5):S45 (abstract).
94. 94. Sobala GM, Schorah CJ, Sanderson M, et al. Ascorbic acid in the human stomach. Gastroenterology 1989;97:357-63.
95. 95. Ruiz b, Rood JC, Fontham ETH, et al. Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am J Gastroenterol 1994;89:533-9.
96. 96. Zhang ZW, Patchett SE, Perrett D, et al. Gastric mucosal and luminal b-carotene concentrations in patients with chronic H. pylori infection. Gut 1996;38(suppl 1):A3.
97. 97. Correa P. The gastric microenvironment determines Helicobacter pylori colonization. Am J Gastroenterol 1995;90:1379-81.
98. 98. Peetsalu A, Maaroos HI, Sipponen P, et al. Long-term effect of vagotomy on gastric mucosa and Helicobacter pylori in duodenal ulcer patients. Scand J Gastroenterol 1991;26(suppl 186):77-83.
99. 99. Jonsson KA, Strom M, Bodemar G, et al. Histologic changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease. Scand J Gastroenterol 1988;23:433-41.
100. 100. Maaroos HI, Saluter V, Uibo R, et al. Seven-year follow-up study of chronic gastritis in gastric ulcer patients. Scand J Gastroenterol 1985; 20:198-204.
101. 101. Garner A, Flemstrom G, Allen A. Gastroduodenal alkaline and mucus secretions. Scand J Gastroenterol 1983;18(suppl 87):25-41.
102. 102. Goldie J, Jalali S, Hunt RH, et al. Study of media and pH requirements for the growth of Campylobacter pylori. Gastroenterology 1988;94:A150 (abstract).
103. 103. Itoh T, Yanagawa Y, Shingaki M, et al. Isolation of Campylobacter pyloridis from human gastric mucosa and characterization of the isolates. Microbiol Immunol 1987;31:603-14.
104. + moving through gastric mucosa. Scand J Gastroenterol 1989;24:761-8.
105. 105. McGowan CC, Cover TL, Blaser MJ. Helicobacter pylori and gastric acid: Biological and therapeutic implications. Gastroenterology 1996; 110:926-38.
106. 106. Clyne M, Lobbing A, Drumm B. Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect Immun 1995;63:1669-73.
107. 107. Logan RPH, Walker MM, Misiewicz JJ, et al. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995;36:12-6.
108. 108. Genta RM, Graham DY. Intestinal metaplasia, not atrophy or achlorhydria creates a hostile environment for Helicobacter pylori. Scand J Gastroenterol 1993;28:924-8.
109. 109. Nebel OT, Fames MF, Castello L. Symptomatic gastro-esophagitis reflux: Incidence and predisposing factors. Dig Dis 1972;17: 993-6.
110. 110. Chang CS, Poon SK, Lien HC, et al. The incidence of reflux esophagitis among the Chinese. Am J Gastroenterol 1997;92:668-71.
111. 2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux esophagitis: A meta-analysis. Eur J Gastroenterol Hepatol 1995;7:467-75.
112. 112. Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, et al. Long-term treatment with omeprazole for refractory reflux esophagitis: Efficacy and safety. Ann Intern Med 1994;121:161-7.
113. 113. The European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997;41:8-13.
114. 114. Lundell L, Havu, N, Andersson A, et al. Gastritis development and acid suppression therapy revisited. Results of a randomised clinical study with long term follow-up. Gastroenterology 1997;112:A28.